{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:54:55Z","timestamp":1788368095878,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2261-8","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T12:25:40Z","timestamp":1487334340000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Prevalence of Human Immunodeficiency Virus and associated factors among Visceral Leishmaniasis infected patients in Northwest Ethiopia: a facility based cross-sectional study"],"prefix":"10.1186","volume":"17","author":[{"given":"Mekuriaw","family":"Alemayehu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamo","family":"Wubshet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nebiyu","family":"Mesfin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abebaw","family":"Gebayehu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,17]]},"reference":[{"key":"2261_CR1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0035-9203(01)90223-8","volume":"95","author":"P Desjeux","year":"2001","unstructured":"Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg. 2001;95:239\u201343.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2261_CR2","unstructured":"WHO: Visceral Leishmaniasis. http:\/\/www.who.int\/leishmaniasis\/visceral_leishmaniasis\/en\/ 2016."},{"key":"2261_CR3","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1128\/IAI.67.10.5258-5264.1999","volume":"67","author":"D Wolday","year":"1999","unstructured":"Wolday D, Akuffo H, Demissie A, Britton S. Role of Leishmania donovani and its lipophosphoglycan in CD4+ T-cell activation-induced human immunodeficiency virus replication. Infect Immun. 1999;67:5258\u201364.","journal-title":"Infect Immun"},{"key":"2261_CR4","first-page":"357","volume":"123","author":"I Cruz","year":"2006","unstructured":"Cruz I, Nieto J, Moreno J, Canavate C, Desjeux P, Alvar J. Leishmania\/HIV co-infections in the second decade. Indian J Med Res. 2006;123:357\u201388.","journal-title":"Indian J Med Res"},{"issue":"Suppl 1","key":"2261_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/000349803225002499","volume":"97","author":"P Desjeux","year":"2003","unstructured":"Desjeux P, Alvar J. Leishmania\/HIV co-infections: epidemiology in Europe. Ann Trop Med Parasitol. 2003;97 Suppl 1:3\u201315.","journal-title":"Ann Trop Med Parasitol"},{"issue":"2","key":"2261_CR6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","volume":"21","author":"J Alvar","year":"2008","unstructured":"Alvar J, Aparicio P, Assefa A, Den Boer M, Canavate C, Dedet JP, et al. The Relationship between Leishmaniasis and AIDS: the second 10 years. Clin Microb Rev. 2008;21(2):334\u201359.","journal-title":"Clin Microb Rev"},{"key":"2261_CR7","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1086\/587899","volume":"46","author":"TR Horst","year":"2008","unstructured":"Horst TR, Colline SM, Ritemeijer K, Bogale A, Davidson NR. Concordant HIV infection and Visceral Leishmaniasis in Ethiopia: The influence of Antiretroviral Treatment and other factors on outcome. Clin Infect Dis. 2008;46:1702\u20139.","journal-title":"Clin Infect Dis"},{"key":"2261_CR8","unstructured":"WHO: HIV\/AIDS progress in 2014. wwwafrowhoint\/en\/ethiopia\/who-country-office-ethiopiahtml 2015."},{"key":"2261_CR9","first-page":"6","volume":"8","author":"D Ermias","year":"2014","unstructured":"Ermias D, Lutgarde L, Koert R, Marleen B, Asrat H, Van G. Visceral Leishmaniasis and HIV Coinfection in East Africa. PLoS Negl Trop Dis. 2014;8:6.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"2261_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.11648\/j.ajls.20140201.11","volume":"2","author":"Y Mulat","year":"2014","unstructured":"Mulat Y, Bayeh A, Wondemagegn M, Yohannes Z, Belay B. Proportional of Visceral Leishmaniasis and Human immune deficiency virus co-infection among clinically confirmed visceral leishmaniasis patients at the endemic foci of the Amahara National Regional State, North-West Ethiopia. Am J Biol Life Sci. 2014;2(1):1\u20137.","journal-title":"Am J Biol Life Sci"},{"key":"2261_CR11","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/00002030-199606001-00014","volume":"10","author":"L Gradoni","year":"1996","unstructured":"Gradoni L, Scalone A, Gramiccia M, Troiani M. Epidemiological surveillance of leishmaniasis in HIV-1-infected individuals in Italy. AIDS. 1996;10:785\u201391.","journal-title":"AIDS"},{"key":"2261_CR12","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/00002030-199212000-00013","volume":"6","author":"F Medrano","year":"1992","unstructured":"Medrano F, Herna\u2019ndez-Quero J, Jime\u2019nez E, Pineda J, Rivero A, Sa\u2019nchez-Quijano A, et al. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain? AIDS. 1992;6:1499\u2013503.","journal-title":"AIDS"},{"key":"2261_CR13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00144435","volume":"12","author":"C Amela","year":"1996","unstructured":"Amela C, Lo\u2019pez-Gay D, Alberdi J, Castilla J. Injecting drug use as risk factor for visceral leishmaniasis in AIDS patients. Eur J Epidemiol. 1996;12:91\u20132.","journal-title":"Eur J Epidemiol"},{"key":"2261_CR14","first-page":"9","volume":"36","author":"GALLARDOJA PINEDA JA","year":"1998","unstructured":"PINEDA JA GALLARDOJA, AS JM, DELGADO J, REGORDA\u2019N C, MORILLAS F, et al. Prevalence of and Factors Associated with Visceral Leishmaniasis in Human Immunodeficiency Virus Type 1-Infected Patients in Southern Spain. J Clini Microbiol. 1998;36:9.","journal-title":"J Clini Microbiol"},{"key":"2261_CR15","first-page":"3","volume":"40","author":"R Rosa","year":"2002","unstructured":"Rosa R, Pineda JA, Delgado J, Mac\u00edas J, Morillas F, Mira JA, et al. Incidence of and Risk Factors for Symptomatic Visceral Leishmaniasis among Human Immunodeficiency Virus Type 1-Infected Patients from Spain in the Era of Highly Active Antiretroviral Therapy. J Clini Microbiol. 2002;40:3.","journal-title":"J Clini Microbiol"},{"key":"2261_CR16","first-page":"53","volume":"21","author":"G Mengistu","year":"2007","unstructured":"Mengistu G, Ayele B. Visceral leishmaniasis and HIV co-infection in patients admitted to Gondar University Hospital, North West Ethiopia. Ethiop J Health Dev. 2007;21:53\u201360.","journal-title":"Ethiop J Health Dev"},{"key":"2261_CR17","unstructured":"FMOH: guideline for diagnosis, treatment and prevention of Leishmaniasis in Ethiopia. 2013. http:\/\/www.moh.gov.et\/ ."},{"key":"2261_CR18","volume-title":"Manual on visceral leishmaniasis","author":"WHO","year":"1996","unstructured":"WHO. Manual on visceral leishmaniasis. Geneva: Report WHO\/Leish\/9640; 1996."},{"key":"2261_CR19","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/JCM.33.7.1742-1745.1995","volume":"33","author":"S Meredith","year":"1995","unstructured":"Meredith S, Kroon NC, Sondorp E, et al. Leish-KIT, a stable direct agglutination test based on freeze-dried antigen for serodiagnosis of visceral leishmaniasis. J Clin Microbiol. 1995;33:1742\u20135.","journal-title":"J Clin Microbiol"},{"key":"2261_CR20","volume-title":"Technical, report: Control of the leishmaniasis","author":"WHO","year":"2010","unstructured":"WHO. Technical, report: Control of the leishmaniasis. Geneva: Report of a meeting of the WHO expert committee; 2010."},{"key":"2261_CR21","volume-title":"Guidelines for management of opportunistic infections and antiretroviral treatment in adolescents and adults in Ethiopia","author":"FMOH","year":"2007","unstructured":"FMOH. Guidelines for management of opportunistic infections and antiretroviral treatment in adolescents and adults in Ethiopia. Addis Ababa: Federal HIV\/AIDS prevention and control office and Federal Minsitry of Health; 2007."},{"issue":"8","key":"2261_CR22","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1365-3156.2008.02143.x","volume":"13","author":"M Sullivan","year":"2008","unstructured":"Sullivan M, Zuguo M, Grummer-Strawn L, Ibrahim P. Haemoglobin adjustments to define anaemia. Trop Med Int Health. 2008;13(8):1267\u201371.","journal-title":"Trop Med Int Health"},{"key":"2261_CR23","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","volume":"2","author":"PJ Guerin","year":"2002","unstructured":"Guerin PJ, Piero O, Shyam S, Marleen B, Croft SL, Philippe D, et al. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis. 2002;2:494\u2013501.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"2261_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003136","volume":"8","author":"J Lindoso","year":"2014","unstructured":"Lindoso J, Cota GF, Da Cruz AM, Goto H, Maia-Elkhoury ANS, et al. Visceral Leishmaniasis and HIV Coinfection in Latin America. PLoS Negl Trop Dis. 2014;8(9), e3136. doi: 10.1371\/journal.pntd.0003136 .","journal-title":"PLoS Negl Trop Dis"},{"key":"2261_CR25","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0035-9203(01)90110-5","volume":"95","author":"K Ritmeijer","year":"2001","unstructured":"Ritmeijer K, Veeken H, Melaku Y, Leal G, Amsalu R, et al. Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome. Trans R Soc Trop Med Hyg. 2001;95:668\u201372.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2261_CR26","first-page":"615","volume-title":"Leishmaniasis in Ethiopia: The Ecology and Epidemiology of Health and Disease in Ethiopia","author":"A Hailu","year":"2006","unstructured":"Hailu A, Gebre-Michael T, Berhe N, Balkew M. Leishmaniasis in Ethiopia: The Ecology and Epidemiology of Health and Disease in Ethiopia. Addis Ababa: Shama Books; 2006. p. 615\u201334."},{"key":"2261_CR27","doi-asserted-by":"publisher","unstructured":"Hurissa Z, Gebre-Silassie S, Hailu W, Tefera T, Lalloo DG, et al.: Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co-infection in northwest Ethiopia. Trop Med Int Health. 2010;15:848\u201355. doi: 10.1111\/j1365-3156201002550x .","DOI":"10.1111\/j1365-3156201002550x"},{"key":"2261_CR28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1046\/j.1365-3156.2003.01088.x","volume":"8","author":"S Lyons","year":"2003","unstructured":"Lyons S, Veeken H, Long J. Visceral leishmaniasis and HIV in Tigray, Ethiopia. Trop Med Int Health. 2003;8:733\u20139.","journal-title":"Trop Med Int Health"},{"key":"2261_CR29","doi-asserted-by":"publisher","unstructured":"Ritmeijer K, Dejenie A, Assefa Y, Hundie TB, Mesure J, et al.: A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection. Clin Infect Dis. 2006;43:357\u201364. doi: 10.1086\/505217 .","DOI":"10.1086\/505217"},{"key":"2261_CR30","unstructured":"FMOH: Ethiopia National Malaria Indicator Survey 2011: Technical Summary. Addis Ababa, Ethiopia pp 1\u201311 2011. http:\/\/www.moh.gov.et\/ ."},{"key":"2261_CR31","unstructured":"FMOH: Health extension program in Ethiopia. Addis Ababa, Ethiopia. 2007 http:\/\/www.moh.gov.et\/ ."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2261-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T16:42:22Z","timestamp":1601656942000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2261-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,17]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2261"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2261-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,17]]},"article-number":"152"}}